Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice

Archives of Pharmacal Research

Volumn 27, Issue 7, 2004, Pages 790-796

  Yun, Se Na ^a   Moon, Sang Jung ^b   Ko, Sung Kwon ^c   Im, Byung Ok ^c   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Sansam Nara Corp   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

Anti diabetic effect; Anti obese effect; High fat diet; Insulin resistance index; Wild ginseng ethanol extract

Indexed keywords

ANTIDIABETIC AGENT; ANTIOBESITY AGENT; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 4; LIPID; MESSENGER RNA; MUSCLE PROTEIN; PLANT EXTRACT; SLC2A4 PROTEIN, MOUSE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BODY COMPOSITION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; FAT INTAKE; GINSENG; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GROWTH, DEVELOPMENT AND AGING; HYPERGLYCEMIA; INSTITUTE FOR CANCER RESEARCH MOUSE; INSULIN RESISTANCE; MALE; METABOLISM; MOUSE; OBESITY; PATHOLOGY;

ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BLOOD GLUCOSE; BODY COMPOSITION; DIETARY FATS; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPIDS; MALE; MICE; MICE, INBRED ICR; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; OBESITY; PANAX; PLANT EXTRACTS; RNA, MESSENGER;

EID: 16644380244     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980150     Document Type: Article

References (13)

1. Assinewe, V. A., Baum, B. R., Gagnon, D., and Arnason, J. T., Phytochemistry of Wild Populations of Panax quinquefolius L. (North American Ginseng). J. Agric. Food. Chem., 51, 4549-4553 (2003).
2. Attele, A. S., Wu, J. A., and Yuan, C. S., Multiple pharmacological effects of ginseng. Biochem. Pharmacol., 58, 1685-1693 (1999).
3. Attele, A. S., Zhou, Y. P., Xie, J. T., Wu, J. A., Zhang, L., and Dey, L., Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes, 51, 1851-1858 (2002).
4. Cavaghan, M. A., Ehrmann, D. A., and Polonsky, K. S., Interaction between insulin resistance and insulin secretion in the development of glucose intolerance. J. Clin. Invest., 106, 329-333 (2000).
5. Chevallier, A., Encyclopedia of herbal medicine. New York: DK Publishing (2000).
6. Chung, S. H., Choi, C. G., and Park, S. H., Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch. Pharm. Res., 24, 214-218 (2001).
7. Cousin, B., Agou, K., Leturque, A., Ferre, P., Girard, J., and Penicaud, L., Molecular and metabolic changes in white adipose tissue of the rat during development of ventromedial hypothalamic obesity. Eur. J. Biochem., 207, 377-382 (1992).
8. Inzucchi, S. E., Oral anihyperglycemic therapy for type 2 diabetes. J. Am. Med. Assoc., 287, 360-372 (2002).
9. Sotaniemi, E. A., Haapakoski, E., and Rautio, A., Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care, 18, 1373-1375 (1995).
10. The Diabetes Control and Complication Trial Research Group, The effect of intensive treatment of diabetes in the development and progression of long term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 329, 977-986 (1993).
11. UK prospective Diabetes Study group (UKPDS). Intensive blood glucose control with sulphonylurias or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837-853 (1998).
12. Vuksan, V., Sievenpiper, J. L., Xu, Z., Wong, E. Y., Jenkins, A. L., and Beljan-Zdrakovic, U., Konjac-mannan and American ginseng: emerging alternative therapies for type 2 diabetes mellitus. J. Am. Coll. Nutr., 20, 370S-380S (2001).
13. Wang, B. X., Advances in study of pharmacology of ginseng. Acta. Phar,. Sin., 12, 477-486 (1965).